Keywords: fda, raises, questions, labopharm, tramadol, canadian, drugmaker

FDA raises questions on Labopharm's tramadol

Article | 09 October 2006

Print This

Canadian drugmaker Labopharm has received an approvable letter from the US Food and Drug Administration for its once-daily formulation of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in